Evidence map›Paper›PMID 23766701›Full record

ReviewTheScientificWorldJournal2013

Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutions.

Diane K Lavett, Van C Lansingh, Marissa J Carter, Kristen A Eckert, Juan C Silva

Abstract readReview
In one paragraph

Review in TheScientificWorldJournal, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Trachoma.BMJ clinical evidence · 2016
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. District-Level Forecast of Achieving Trachoma Elimination as a Public Health Problem By 2030: An Ensemble Modelling Approach.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Prevalence of Active Trachoma and Associated Factors in Areka Town, South Ethiopia, 2018.Interdisciplinary perspectives on infectious diseases · 2020
    Article
  17. Article
  18. Survey, Culture, and Genome Analysis of OcularFrontiers in cellular and infection microbiology · 2016
    Article
  19. Social Sciences for the Prevention of Blindness.Tropical medicine and health · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diane K LavettStrategic Solutions, Inc., 1143 Salsbury Avenue, Cody, WY 82414, USA.
Van C Lansingh
Marissa J Carter
Kristen A Eckert
Juan C Silva

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the inception of (the Global Elimination of Blinding Trachoma) GET 2020 in 1997 and the implementation of the SAFE strategy a year later, much progress has been made toward lowering the prevalence of trachoma worldwide with elimination of the disease in some countries. However, high recurrence of trichiasis after surgery, difficulty in controlling the reemergence of infection after mass distribution of azithromycin in some communities, the incomplete understanding of environment in relation to the disease, and the difficulty in establishing the prevalence of the disease in low endemic areas are some of the issues still facing completion of the GET 2020 goals. In this narrative review, literature was searched from 1998 to January 2013 in PubMed for original studies and reviews. Reasons for these ongoing problems are discussed, and several suggestions are made as avenues for exploration in relation to improving the SAFE strategy with emphasis on improving surgical quality and management of the mass treatment with antibiotics. In addition, more research needs to be done to better understand the approach to improve sanitation, hygiene, and environment. The main conclusion of this review is that scale-up is needed for all SAFE components, and more research should be generated from communities outside of Africa and Asia.

Indexed as

Practice Guidelines as TopicBlindnessGlobal HealthHumansTrachomaWorld Health Organization

Identifiers

PMID23766701
PMCPMC3671555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.